ⓘ 8th Edition 2026 Revenue: USD Million/Billion

Global Organ on a chip Systems Market Analysis 2026

Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence — Revenue, Volume, Production, Trade Analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.

Base / Forecast
2025/2034
▸ Timeline
Data TimelineHistorical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034
Product & Service SegmentProduct & Service, Products, , Instruments, Organ-on-a-Chip Devices, Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others, , Services
Application SegmentDrug Discovery, Toxicology Research, Others
End-User SegmentAcademic and Research Institutes, Pharmaceutical & Biotechnology Companies, Others
Regions & Countries
  • North America (United States, Canada, Mexico)
  • Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
  • South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
  • Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
  • Africa (East Africa, West Africa, North Africa, South Africa)
Global Organ on a chip Systems Market Analysis 2026
Global Organ on a chip Systems Market Analysis 2026
250+ Pages · Global · 4.8
Author By: Supriya Yadav
Industry Expert: Not Disclosed (NDA)
Data Updated: April 2026
Report ID: CMR655561  |  Pages: 250+
Rating: 4.8  |  Review: 6
Format: Athenaeum Dashboard, PDF, Excel, MS Word, Cloud & AI Assistant
📅 Book a consultation
🔍 Explore Global Organ on a chip Systems Market Analysis Services: Bespoke Data  |  Athenaeum AI Dashboard  |  Market Surveys  |  Expert-Led Analysis  |  Market Size  |  Key Drivers  |  Emerging Trends    👉 Free Sample  |  Book Appointment      

Global Organ on a chip Systems Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

USD Million/Billion
Loading…

Share Distribution

Loading…

Market Dynamics of Global Organ on a chip Systems Market Analysis

Growth Drivers

Increasing demand for personalized medicine propels the organ-on-a-chip market. Growing government and private institution funding fuels the growth of the organ-on-chip market.  

Restraints

Lack of standardization and low throughput of current organ-on-chip technology restrain the growth of organ on the chip market. 

~ Trends

The development of multi-organ-on-chip systems represents a significant opportunity to grow the organ-on-a-chip market.

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Global Organ on a chip Systems Market Analysis — Presence

Interactive World Map

Click countries to explore
Loading map…

Regional and Country Analysis

  • North America — United States, Canada, Mexico
  • Europe — United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe
  • Asia Pacific — China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC
  • South America — Brazil, Argentina, Colombia, Peru, Chile, Rest of South America
  • Middle East — Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East
  • Africa — East Africa, West Africa, North Africa, South Africa

Segmentation Analysis

Market size by (Illustrative, 2025)
Share distribution (2025)

Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.

To learn more about market share and segmentation, request the free sample pages.

Competitive Landscape of the Global Organ on a chip Systems Market Analysis

In no particular order of rank

Competitive Landscape: Organ-On-a-Chip Market

The competitive landscape of the industry is defined by established pharmaceutical and biotechnology companies that provide pharmaceutical treatment products and advanced technology products which are competing for market share. To expand their range of products, major companies are taking part in strategic efforts such as collaborations, investment, collaboration, and new launches. Companies are proactively using multiple strategies to tackle the increasing need for organ chips.
For instance, in December 2022, Tessara Therapeutics entered into collaboration with France-based organ-on-a-chip company NETRI on the development of a next-generation brain-on-a-chip model for neurological disease research.
Source:(https://biomelbourne.org/tessara-therapeutics-and-netri-to-collaborate-on-the-development-of-next-generation-3d-brain-on-a-chip-model/)
 

Click any bar or cell to request the full company profile
Company2022 (A)2023 (A)2024 (A)2025 (A)
Emulate••• ••• ••• •••
Inc.••• ••• ••• •••
MIMETAS B.V.••• ••• ••• •••
Valo Health••• ••• ••• •••
Nortis••• ••• ••• •••
Inc.••• ••• ••• •••
AxoSim••• ••• ••• •••
BICO - THE BIO CONVERGENCE COMPANY••• ••• ••• •••
CN Bio Innovations Ltd••• ••• ••• •••
SynVivo••• ••• ••• •••
Inc.••• ••• ••• •••
The Charles Stark Draper Laboratory••• ••• ••• •••
Inc••• ••• ••• •••
AlveoliX AG••• ••• ••• •••

Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.

Request company profile for validation →

Report Scope & Analysis

According to Cognitive Market Research, the Global  Organ-On-a-Chip market was USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031.

North America held the major market share for more than XX% of the global revenue with a market size of USD XX  million in 2024 and will grow at a compound annual growth rate (CAGR) of XX % from 2024 to 2031.
The Europe region is the fastest growing market with a CAGR of XX% from 2024 to 2031 and it is projected that it will grow at a CAGR of XX% in the future.
Asia Pacific accounted for a market share of over XX% of the global revenue with a market size of USD XX million.
Latin America had a market share for more than XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Middle East and Africa had a market share of around XX% of the global revenue and was estimated at a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
The organ-on-a-chip held the highest market revenue share in 2024.
 

Introduction of the Organ-On-a-Chip Market 

Organ-on-chips are devices that include small-scale, organic, or artificial tissues created inside microfluidic chips. The chips are designed to maintain tissue-specific functions and control cell microenvironments to more closely mimic human physiology. The growing interest in organ-on-a-chip (OoC) technology may be ascribed to the convergence of advancements in tissue engineering and microfabrication. OoCs are becoming increasingly popular as the next generation of investigative tools for studying human pathophysiology and the effects of treatments on the body. Since there are as many OoCs as solicitations, it is difficult for modern academics to understand what makes one OoC more useful for a certain application than another.
The growth of the market is attributed to the rising need for kidneys, liver, heart, and lungs. By designing operational organs in labs that can address the shortage of donor organs, this technique can help meet the need for organ transplants. Still, the market's progress may be hampered by the soaring costs of organ-on-a-chip devices and the early stage of organ-on-chip technology development. Despite this, increasing healthcare costs in developing nations and a rise in harmful diseases, the need for organ transplantation, and animal testing for medication development are all expected to contribute to market expansion.
 

With the help of the above study about the organ-on-a-chip market, it can be concluded that the market for organ-on-a-chip worldwide is expected to develop significantly shortly. From the report, one can understand and infer the market dynamics, segmentations, status and trends, and key players in the market. It provides data regarding various topics such as market dimensions, prevailing trends, competitive landscape, and the outlook for prospective expansion. This allows the reader to understand and access reliable data about the market and industry.

Analyst Conclusion

With the help of the above study about the organ-on-a-chip market, it can be concluded that the market for organ-on-a-chip worldwide is expected to develop significantly shortly. From the report, one can understand and infer the market dynamics, segmentations, status and trends, and key players in the market. It provides data regarding various topics such as market dimensions, prevailing trends, competitive landscape, and the outlook for prospective expansion. This allows the reader to understand and access reliable data about the market and industry.

Supriya Yadav
Research Analyst at Cognitive Market Research · Cognitive Market Research

As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions. My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients. I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.

Frequently Asked Questions

Global Organ on a chip Systems Market Analysis market size and growth rate is provided in the report covering 2021-2025 historical and 2025-2033 forecast data.
Major factors including drivers, restraints, opportunities and challenges are analyzed with detailed insights.
Top manufacturers Emulate, Inc., MIMETAS B.V., Valo Health, Nortis, Inc., AxoSim, BICO - THE BIO CONVERGENCE COMPANY, CN Bio Innovations Ltd, SynVivo, Inc., The Charles Stark Draper Laboratory, Inc, AlveoliX AG and others are profiled in the report.
Segments include Product & Service, Application and additional sub-segments.
Regional analysis covers all major markets. The report identifies the dominant region and provides country-level data.
Sample pages can be obtained on demand from the website. 24/7 chat support and direct call services are available.

Reviews

No reviews yet — be the first!

Rate this report

Global Organ on a chip Systems Market Analysis — Table of Contents

Disclaimer: Redacted sample for representative purposes. Charts and data do not depict actual statistics. TOC varies by license selection.
License Edition

Product & Service Product & Service, Products, , Instruments, Organ-on-a-Chip Devices, Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others, , Services
Application Drug Discovery, Toxicology Research, Others
End-User Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, Others
List of Competitors Emulate, Inc., MIMETAS B.V., Valo Health, Nortis, Inc., AxoSim, BICO - THE BIO CONVERGENCE COMPANY, CN Bio Innovations Ltd, SynVivo, Inc., The Charles Stark Draper Laboratory, Inc, AlveoliX AG

  • 1.1 Global Power Realignment & Strategic Alliances
  • 1.2 Geopolitical Risk Landscape & Conflict Hotspots
  • 1.3 International Trade Relations & Market Access Environment
  • 1.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
  • 1.5 Supply Chain Resilience, Localization & Resource Nationalism
  • 1.6 Technology Sovereignty & Digital Geopolitics
  • 1.7 Strategic Implications for Investment, Growth & Market Entry

  • 2.1 Competitive Landscape Disruption & Strategic Shifts
  • 2.2 AI-Driven Transformation of Industry Value Chain
  • 2.3 Evolution of Business Models & Revenue Streams
  • 2.4 Operational Efficiency & Cost Structure Transformation
  • 2.5 Product, Service & Innovation Acceleration
  • 2.6 Customer Behavior & Demand Evolution
  • 2.7 Future Outlook: AI-Led Market Evolution & Strategic Implications

  • 3.1 Global Organ on a chip Systems Revenue Market Size, Trend Analysis 2022 - 2034
  • Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

    3.2 Global Organ on a chip Systems Market Size By Regions 2022 - 2034
    • 3.2.1 Global Organ on a chip Systems Revenue Market Size By Region
  • 3.3 Global Organ on a chip Systems Market Size By Product & Service 2022 - 2034
    • 3.3.1 Product & Service Market Size
    • 3.3.2 Products Market Size
    • 3.3.3 Market Size
    • 3.3.4 Instruments Market Size
    • 3.3.5 Organ-on-a-Chip Devices Market Size
    • 3.3.6 Liver-on-a-Chip Market Size
    • 3.3.7 Lung-on-a-Chip Market Size
    • 3.3.8 Intestine-on-a-Chip Market Size
    • 3.3.9 Kidney-on-a-Chip Market Size
    • 3.3.10 Heart-on-a-Chip Market Size
    • 3.3.11 Others Market Size
    • 3.3.12 Market Size
    • 3.3.13 Services Market Size
  • 3.4 Global Organ on a chip Systems Market Size By Application 2022 - 2034
    • 3.4.1 Drug Discovery Market Size
    • 3.4.2 Toxicology Research Market Size
    • 3.4.3 Others Market Size
  • 3.5 Global Organ on a chip Systems Market Size By End-User 2022 - 2034
    • 3.5.1 Academic and Research Institutes Market Size
    • 3.5.2 Pharmaceutical & Biotechnology Companies Market Size
    • 3.5.3 Others Market Size
  • 3.6 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
  • You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)

    3.7 Executive Summary Global Market (2021 vs 2025 vs 2033)
    • 3.7.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
    • 3.7.2 Global Market Revenue Split By Product & Service
    • 3.7.3 Global Market Revenue Split By Application
    • 3.7.4 Global Market Revenue Split By End-User
    • Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable

      3.7.5 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities

  • 4.1 North America Organ on a chip Systems Market Outlook
    • 4.1.1 North America Organ on a chip Systems Market Size 2022 - 2034
    • 4.1.2 North America Organ on a chip Systems Market Size By Country 2022 - 2034
    • 4.1.3 North America Organ on a chip Systems Market Size by Product & Service 2022 - 2034
      • 4.1.3.1 North America Product & Service Market Size
      • 4.1.3.2 North America Products Market Size
      • 4.1.3.3 North America Market Size
      • 4.1.3.4 North America Instruments Market Size
      • 4.1.3.5 North America Organ-on-a-Chip Devices Market Size
      • 4.1.3.6 North America Liver-on-a-Chip Market Size
      • 4.1.3.7 North America Lung-on-a-Chip Market Size
      • 4.1.3.8 North America Intestine-on-a-Chip Market Size
      • 4.1.3.9 North America Kidney-on-a-Chip Market Size
      • 4.1.3.10 North America Heart-on-a-Chip Market Size
      • 4.1.3.11 North America Others Market Size
      • 4.1.3.12 North America Market Size
      • 4.1.3.13 North America Services Market Size
    • 4.1.4 North America Organ on a chip Systems Market Size by Application 2022 - 2034
      • 4.1.4.1 North America Drug Discovery Market Size
      • 4.1.4.2 North America Toxicology Research Market Size
      • 4.1.4.3 North America Others Market Size
    • 4.1.5 North America Organ on a chip Systems Market Size by End-User 2022 - 2034
      • 4.1.5.1 North America Academic and Research Institutes Market Size
      • 4.1.5.2 North America Pharmaceutical & Biotechnology Companies Market Size
      • 4.1.5.3 North America Others Market Size

  • 5.1 Europe Organ on a chip Systems Market Outlook
    • 5.1.1 Europe Organ on a chip Systems Market Size 2022 - 2034
    • 5.1.2 Europe Organ on a chip Systems Market Size By Country 2022 - 2034
    • 5.1.3 Europe Organ on a chip Systems Market Size by Product & Service 2022 - 2034
      • 5.1.3.1 Europe Product & Service Market Size
      • 5.1.3.2 Europe Products Market Size
      • 5.1.3.3 Europe Market Size
      • 5.1.3.4 Europe Instruments Market Size
      • 5.1.3.5 Europe Organ-on-a-Chip Devices Market Size
      • 5.1.3.6 Europe Liver-on-a-Chip Market Size
      • 5.1.3.7 Europe Lung-on-a-Chip Market Size
      • 5.1.3.8 Europe Intestine-on-a-Chip Market Size
      • 5.1.3.9 Europe Kidney-on-a-Chip Market Size
      • 5.1.3.10 Europe Heart-on-a-Chip Market Size
      • 5.1.3.11 Europe Others Market Size
      • 5.1.3.12 Europe Market Size
      • 5.1.3.13 Europe Services Market Size
    • 5.1.4 Europe Organ on a chip Systems Market Size by Application 2022 - 2034
      • 5.1.4.1 Europe Drug Discovery Market Size
      • 5.1.4.2 Europe Toxicology Research Market Size
      • 5.1.4.3 Europe Others Market Size
    • 5.1.5 Europe Organ on a chip Systems Market Size by End-User 2022 - 2034
      • 5.1.5.1 Europe Academic and Research Institutes Market Size
      • 5.1.5.2 Europe Pharmaceutical & Biotechnology Companies Market Size
      • 5.1.5.3 Europe Others Market Size

  • 6.1 Asia Pacific Organ on a chip Systems Market Outlook
    • 6.1.1 Asia Pacific Organ on a chip Systems Market Size 2022 - 2034
    • 6.1.2 Asia Pacific Organ on a chip Systems Market Size By Country 2022 - 2034
    • 6.1.3 Asia Pacific Organ on a chip Systems Market Size by Product & Service 2022 - 2034
      • 6.1.3.1 Asia Pacific Product & Service Market Size
      • 6.1.3.2 Asia Pacific Products Market Size
      • 6.1.3.3 Asia Pacific Market Size
      • 6.1.3.4 Asia Pacific Instruments Market Size
      • 6.1.3.5 Asia Pacific Organ-on-a-Chip Devices Market Size
      • 6.1.3.6 Asia Pacific Liver-on-a-Chip Market Size
      • 6.1.3.7 Asia Pacific Lung-on-a-Chip Market Size
      • 6.1.3.8 Asia Pacific Intestine-on-a-Chip Market Size
      • 6.1.3.9 Asia Pacific Kidney-on-a-Chip Market Size
      • 6.1.3.10 Asia Pacific Heart-on-a-Chip Market Size
      • 6.1.3.11 Asia Pacific Others Market Size
      • 6.1.3.12 Asia Pacific Market Size
      • 6.1.3.13 Asia Pacific Services Market Size
    • 6.1.4 Asia Pacific Organ on a chip Systems Market Size by Application 2022 - 2034
      • 6.1.4.1 Asia Pacific Drug Discovery Market Size
      • 6.1.4.2 Asia Pacific Toxicology Research Market Size
      • 6.1.4.3 Asia Pacific Others Market Size
    • 6.1.5 Asia Pacific Organ on a chip Systems Market Size by End-User 2022 - 2034
      • 6.1.5.1 Asia Pacific Academic and Research Institutes Market Size
      • 6.1.5.2 Asia Pacific Pharmaceutical & Biotechnology Companies Market Size
      • 6.1.5.3 Asia Pacific Others Market Size

  • 7.1 South America Organ on a chip Systems Market Outlook
    • 7.1.1 South America Organ on a chip Systems Market Size 2022 - 2034
    • 7.1.2 South America Organ on a chip Systems Market Size By Country 2022 - 2034
    • 7.1.3 South America Organ on a chip Systems Market Size by Product & Service 2022 - 2034
      • 7.1.3.1 South America Product & Service Market Size
      • 7.1.3.2 South America Products Market Size
      • 7.1.3.3 South America Market Size
      • 7.1.3.4 South America Instruments Market Size
      • 7.1.3.5 South America Organ-on-a-Chip Devices Market Size
      • 7.1.3.6 South America Liver-on-a-Chip Market Size
      • 7.1.3.7 South America Lung-on-a-Chip Market Size
      • 7.1.3.8 South America Intestine-on-a-Chip Market Size
      • 7.1.3.9 South America Kidney-on-a-Chip Market Size
      • 7.1.3.10 South America Heart-on-a-Chip Market Size
      • 7.1.3.11 South America Others Market Size
      • 7.1.3.12 South America Market Size
      • 7.1.3.13 South America Services Market Size
    • 7.1.4 South America Organ on a chip Systems Market Size by Application 2022 - 2034
      • 7.1.4.1 South America Drug Discovery Market Size
      • 7.1.4.2 South America Toxicology Research Market Size
      • 7.1.4.3 South America Others Market Size
    • 7.1.5 South America Organ on a chip Systems Market Size by End-User 2022 - 2034
      • 7.1.5.1 South America Academic and Research Institutes Market Size
      • 7.1.5.2 South America Pharmaceutical & Biotechnology Companies Market Size
      • 7.1.5.3 South America Others Market Size

  • 8.1 Middle East Organ on a chip Systems Market Outlook
    • 8.1.1 Middle East Organ on a chip Systems Market Size 2022 - 2034
    • 8.1.2 Middle East Organ on a chip Systems Market Size By Country 2022 - 2034
    • 8.1.3 Middle East Organ on a chip Systems Market Size by Product & Service 2022 - 2034
      • 8.1.3.1 Middle East Product & Service Market Size
      • 8.1.3.2 Middle East Products Market Size
      • 8.1.3.3 Middle East Market Size
      • 8.1.3.4 Middle East Instruments Market Size
      • 8.1.3.5 Middle East Organ-on-a-Chip Devices Market Size
      • 8.1.3.6 Middle East Liver-on-a-Chip Market Size
      • 8.1.3.7 Middle East Lung-on-a-Chip Market Size
      • 8.1.3.8 Middle East Intestine-on-a-Chip Market Size
      • 8.1.3.9 Middle East Kidney-on-a-Chip Market Size
      • 8.1.3.10 Middle East Heart-on-a-Chip Market Size
      • 8.1.3.11 Middle East Others Market Size
      • 8.1.3.12 Middle East Market Size
      • 8.1.3.13 Middle East Services Market Size
    • 8.1.4 Middle East Organ on a chip Systems Market Size by Application 2022 - 2034
      • 8.1.4.1 Middle East Drug Discovery Market Size
      • 8.1.4.2 Middle East Toxicology Research Market Size
      • 8.1.4.3 Middle East Others Market Size
    • 8.1.5 Middle East Organ on a chip Systems Market Size by End-User 2022 - 2034
      • 8.1.5.1 Middle East Academic and Research Institutes Market Size
      • 8.1.5.2 Middle East Pharmaceutical & Biotechnology Companies Market Size
      • 8.1.5.3 Middle East Others Market Size

  • 9.1 Africa Organ on a chip Systems Market Outlook
    • 9.1.1 Africa Organ on a chip Systems Market Size 2022 - 2034
    • 9.1.2 Africa Organ on a chip Systems Market Size By Country 2022 - 2034
    • 9.1.3 Africa Organ on a chip Systems Market Size by Product & Service 2022 - 2034
      • 9.1.3.1 Africa Product & Service Market Size
      • 9.1.3.2 Africa Products Market Size
      • 9.1.3.3 Africa Market Size
      • 9.1.3.4 Africa Instruments Market Size
      • 9.1.3.5 Africa Organ-on-a-Chip Devices Market Size
      • 9.1.3.6 Africa Liver-on-a-Chip Market Size
      • 9.1.3.7 Africa Lung-on-a-Chip Market Size
      • 9.1.3.8 Africa Intestine-on-a-Chip Market Size
      • 9.1.3.9 Africa Kidney-on-a-Chip Market Size
      • 9.1.3.10 Africa Heart-on-a-Chip Market Size
      • 9.1.3.11 Africa Others Market Size
      • 9.1.3.12 Africa Market Size
      • 9.1.3.13 Africa Services Market Size
    • 9.1.4 Africa Organ on a chip Systems Market Size by Application 2022 - 2034
      • 9.1.4.1 Africa Drug Discovery Market Size
      • 9.1.4.2 Africa Toxicology Research Market Size
      • 9.1.4.3 Africa Others Market Size
    • 9.1.5 Africa Organ on a chip Systems Market Size by End-User 2022 - 2034
      • 9.1.5.1 Africa Academic and Research Institutes Market Size
      • 9.1.5.2 Africa Pharmaceutical & Biotechnology Companies Market Size
      • 9.1.5.3 Africa Others Market Size

  • 10.1 Top Competitors Analysis
    • (Subject to Data Availability (Private Players))

      10.1.1 Global Organ on a chip Systems Market Revenue and Share by Key Players
    • 10.1.2 Top Players Ranking 2024
    • 10.1.3 New Product Launch Analysis
    • 10.1.4 Industry Mergers and Acquisition Analysis
  • 10.2 Company Profile (Data Subject to Availability) Sample Format
    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.1 Emulate
      • 10.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.1.2 Business Overview
      • 10.2.1.3 Financials (Subject to data availability)
      • 10.2.1.4 R&D Investment (Subject to data availability)
      • 10.2.1.5 Product Types Specification
      • 10.2.1.6 Business Strategy
      • 10.2.1.7 Recent Developments
      • 10.2.1.8 Management Change
      • 10.2.1.9 S.W.O.T Analysis
    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.2 Inc.
      • 10.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.2.2 Business Overview
      • 10.2.2.3 Financials (Subject to data availability)
      • 10.2.2.4 R&D Investment (Subject to data availability)
      • 10.2.2.5 Product Types Specification
      • 10.2.2.6 Business Strategy
      • 10.2.2.7 Recent Developments
      • 10.2.2.8 Management Change
      • 10.2.2.9 S.W.O.T Analysis
    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.3 MIMETAS B.V.
      • 10.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.3.2 Business Overview
      • 10.2.3.3 Financials (Subject to data availability)
      • 10.2.3.4 R&D Investment (Subject to data availability)
      • 10.2.3.5 Product Types Specification
      • 10.2.3.6 Business Strategy
      • 10.2.3.7 Recent Developments
      • 10.2.3.8 Management Change
      • 10.2.3.9 S.W.O.T Analysis
    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.4 Valo Health
      • 10.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.4.2 Business Overview
      • 10.2.4.3 Financials (Subject to data availability)
      • 10.2.4.4 R&D Investment (Subject to data availability)
      • 10.2.4.5 Product Types Specification
      • 10.2.4.6 Business Strategy
      • 10.2.4.7 Recent Developments
      • 10.2.4.8 Management Change
      • 10.2.4.9 S.W.O.T Analysis
    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.5 Nortis
      • 10.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.5.2 Business Overview
      • 10.2.5.3 Financials (Subject to data availability)
      • 10.2.5.4 R&D Investment (Subject to data availability)
      • 10.2.5.5 Product Types Specification
      • 10.2.5.6 Business Strategy
      • 10.2.5.7 Recent Developments
      • 10.2.5.8 Management Change
      • 10.2.5.9 S.W.O.T Analysis
    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.6 Inc.
      • 10.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.6.2 Business Overview
      • 10.2.6.3 Financials (Subject to data availability)
      • 10.2.6.4 R&D Investment (Subject to data availability)
      • 10.2.6.5 Product Types Specification
      • 10.2.6.6 Business Strategy
      • 10.2.6.7 Recent Developments
      • 10.2.6.8 Management Change
      • 10.2.6.9 S.W.O.T Analysis
    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.7 AxoSim
      • 10.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.7.2 Business Overview
      • 10.2.7.3 Financials (Subject to data availability)
      • 10.2.7.4 R&D Investment (Subject to data availability)
      • 10.2.7.5 Product Types Specification
      • 10.2.7.6 Business Strategy
      • 10.2.7.7 Recent Developments
      • 10.2.7.8 Management Change
      • 10.2.7.9 S.W.O.T Analysis
    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.8 BICO - THE BIO CONVERGENCE COMPANY
      • 10.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.8.2 Business Overview
      • 10.2.8.3 Financials (Subject to data availability)
      • 10.2.8.4 R&D Investment (Subject to data availability)
      • 10.2.8.5 Product Types Specification
      • 10.2.8.6 Business Strategy
      • 10.2.8.7 Recent Developments
      • 10.2.8.8 Management Change
      • 10.2.8.9 S.W.O.T Analysis
    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.9 CN Bio Innovations Ltd
      • 10.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.9.2 Business Overview
      • 10.2.9.3 Financials (Subject to data availability)
      • 10.2.9.4 R&D Investment (Subject to data availability)
      • 10.2.9.5 Product Types Specification
      • 10.2.9.6 Business Strategy
      • 10.2.9.7 Recent Developments
      • 10.2.9.8 Management Change
      • 10.2.9.9 S.W.O.T Analysis
    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.10 SynVivo
      • 10.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.10.2 Business Overview
      • 10.2.10.3 Financials (Subject to data availability)
      • 10.2.10.4 R&D Investment (Subject to data availability)
      • 10.2.10.5 Product Types Specification
      • 10.2.10.6 Business Strategy
      • 10.2.10.7 Recent Developments
      • 10.2.10.8 Management Change
      • 10.2.10.9 S.W.O.T Analysis
    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.11 Inc.
      • 10.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.11.2 Business Overview
      • 10.2.11.3 Financials (Subject to data availability)
      • 10.2.11.4 R&D Investment (Subject to data availability)
      • 10.2.11.5 Product Types Specification
      • 10.2.11.6 Business Strategy
      • 10.2.11.7 Recent Developments
      • 10.2.11.8 Management Change
      • 10.2.11.9 S.W.O.T Analysis
    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.12 The Charles Stark Draper Laboratory
      • 10.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.12.2 Business Overview
      • 10.2.12.3 Financials (Subject to data availability)
      • 10.2.12.4 R&D Investment (Subject to data availability)
      • 10.2.12.5 Product Types Specification
      • 10.2.12.6 Business Strategy
      • 10.2.12.7 Recent Developments
      • 10.2.12.8 Management Change
      • 10.2.12.9 S.W.O.T Analysis
    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.13 Inc
      • 10.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.13.2 Business Overview
      • 10.2.13.3 Financials (Subject to data availability)
      • 10.2.13.4 R&D Investment (Subject to data availability)
      • 10.2.13.5 Product Types Specification
      • 10.2.13.6 Business Strategy
      • 10.2.13.7 Recent Developments
      • 10.2.13.8 Management Change
      • 10.2.13.9 S.W.O.T Analysis
    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.14 AlveoliX AG
      • 10.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.14.2 Business Overview
      • 10.2.14.3 Financials (Subject to data availability)
      • 10.2.14.4 R&D Investment (Subject to data availability)
      • 10.2.14.5 Product Types Specification
      • 10.2.14.6 Business Strategy
      • 10.2.14.7 Recent Developments
      • 10.2.14.8 Management Change
      • 10.2.14.9 S.W.O.T Analysis

  • 11.1 Market Drivers
  • 11.2 Market Restraints
  • 11.3 Market Trends
  • 11.4 Market Opportunity
  • 11.5 Technological Road Map (Subject to Data Availability)
  • 11.6 Product Life Cycle (Subject to Data Availability)
  • 11.7 Customer and Buyer Behavior Analysis
    • 11.7.1 Consumer Demographics and Target Audience Assessment
    • 11.7.2 Consumer Purchase Behavior and Demand Assessment
    • 11.7.3 Consumer Pricing Dynamics and Affordability Assessment
    • 11.7.4 Digital Consumer Engagement and Online Adoption Analysis
    • 11.7.5 Future Consumption Trends and Demand Evolution Analysis
    • 11.7.6 Enterprise Procurement & Purchasing Behavior Analysis
    • 11.7.7 Buyer Decision-Making & Purchase Influence Assessment
    • 11.7.8 Customer Expectations & Service Experience Evaluation
    • 11.7.9 Vendor Selection & Supplier Preference Analysis
    • 11.7.10 Customer Retention & Loyalty Strategy Assessment
    • 11.7.11 Pricing Sensitivity & Value Perception Analysis
    • 11.7.12 Customer Segmentation & Demand Pattern Analysis
    • 11.7.13 Relationship Management & Strategic Partnership Trends
  • 11.8 Market Attractiveness Analysis
  • 11.9 PESTEL Analysis
    • 11.9.1 Political Factors
    • 11.9.2 Economic Factors
    • 11.9.3 Social Factors
    • 11.9.4 Technological Factors
    • 11.9.5 Legal Factors
    • 11.9.6 Environmental Factors
  • 11.10 Industrial Chain Analysis (Subject to Data Availability)
    • 11.10.1 Industry Chain Analysis
    • 11.10.2 Manufacturing Cost Analysis
    • 11.10.3 Supply Side Analysis
      • 11.10.3.1 Raw Material Analysis
      • 11.10.3.2 Raw Material Procurement Analysis
      • 11.10.3.3 Raw Material Price Trend Analysis
  • 11.11 Porter’s Five Forces Analysis
    • 11.11.1 Bargaining Power of Suppliers
    • 11.11.2 Bargaining Power of Buyers
    • 11.11.3 Threat of New Entrants
    • 11.11.4 Threat of Substitutes
    • 11.11.5 Degree of Competition
  • 11.12 Patent Analysis (Subject to Data Availability)
  • 11.13 ESG Analysis

  • 12.1 Product & Service
    • 12.1.1 Global Organ on a chip Systems Revenue Market Size and Share by Product & Service 2022 - 2034
  • 12.2 Products
    • 12.2.1 Global Organ on a chip Systems Revenue Market Size and Share by Products 2022 - 2034
  • 12.3
    • 12.3.1 Global Organ on a chip Systems Revenue Market Size and Share by 2022 - 2034
  • 12.4 Instruments
    • 12.4.1 Global Organ on a chip Systems Revenue Market Size and Share by Instruments 2022 - 2034
  • 12.5 Organ-on-a-Chip Devices
    • 12.5.1 Global Organ on a chip Systems Revenue Market Size and Share by Organ-on-a-Chip Devices 2022 - 2034
  • 12.6 Liver-on-a-Chip
    • 12.6.1 Global Organ on a chip Systems Revenue Market Size and Share by Liver-on-a-Chip 2022 - 2034
  • 12.7 Lung-on-a-Chip
    • 12.7.1 Global Organ on a chip Systems Revenue Market Size and Share by Lung-on-a-Chip 2022 - 2034
  • 12.8 Intestine-on-a-Chip
    • 12.8.1 Global Organ on a chip Systems Revenue Market Size and Share by Intestine-on-a-Chip 2022 - 2034
  • 12.9 Kidney-on-a-Chip
    • 12.9.1 Global Organ on a chip Systems Revenue Market Size and Share by Kidney-on-a-Chip 2022 - 2034
  • 12.10 Heart-on-a-Chip
    • 12.10.1 Global Organ on a chip Systems Revenue Market Size and Share by Heart-on-a-Chip 2022 - 2034
  • 12.11 Others
    • 12.11.1 Global Organ on a chip Systems Revenue Market Size and Share by Others 2022 - 2034
  • 12.12
    • 12.12.1 Global Organ on a chip Systems Revenue Market Size and Share by 2022 - 2034
  • 12.13 Services
    • 12.13.1 Global Organ on a chip Systems Revenue Market Size and Share by Services 2022 - 2034

  • 13.1 Drug Discovery
    • 13.1.1 Global Organ on a chip Systems Revenue Market Size and Share by Drug Discovery 2022 - 2034
  • 13.2 Toxicology Research
    • 13.2.1 Global Organ on a chip Systems Revenue Market Size and Share by Toxicology Research 2022 - 2034
  • 13.3 Others
    • 13.3.1 Global Organ on a chip Systems Revenue Market Size and Share by Others 2022 - 2034

  • 14.1 Academic and Research Institutes
    • 14.1.1 Global Organ on a chip Systems Revenue Market Size and Share by Academic and Research Institutes 2022 - 2034
  • 14.2 Pharmaceutical & Biotechnology Companies
    • 14.2.1 Global Organ on a chip Systems Revenue Market Size and Share by Pharmaceutical & Biotechnology Companies 2022 - 2034
  • 14.3 Others
    • 14.3.1 Global Organ on a chip Systems Revenue Market Size and Share by Others 2022 - 2034

  • 15.1 Company Gap Assessment Analysis
  • 15.2 Product & Service Portfolio Gap Analysis
  • 15.3 Demand-Supply Imbalance Analysis
  • 15.4 Market Opportunity & Unmet Needs Analysis
  • 15.5 Technology Adoption & Digital Transformation Gap Analysis
  • 15.6 Operational Efficiency & Process Gap Analysis
  • 15.7 Infrastructure & Capacity Gap Analysis
  • 15.8 Geographic Coverage & Distribution Gap Analysis
  • 15.9 Investment Opportunity & Funding Gap Analysis
  • 15.10 Pricing Structure & Margin Gap Analysis
  • 15.11 Innovation & R&D Capability Gap Analysis
  • 15.12 Policy, Compliance & Regulatory Gap Analysis
  • 15.13 Customer Experience & Expectation Gap Analysis
  • 15.14 Future Growth Opportunity Gap Analysis
  • 15.15 Market Accessibility & Penetration Gap Analysis

  • 16.1 Strategic Commercialization & Pricing Assessment

  • 17.1 Gross Margin Overview and Industry Profitability Trends
  • 17.2 Regional Gross Margin Performance Analysis
  • 17.3 Supply Chain and Distribution Impact on Gross Margins
  • 17.4 Pricing Strategy and Value-Added Margin Assessment
  • 17.5 Key Factors Influencing Gross Margin Variability
  • 17.6 Future Gross Margin Outlook and Profitability Trends

  • 18.1 Key Takeaways
  • Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

    18.2 Analyst Point of View
  • 18.3 Assumptions and Acronyms

  • 19.1 Primary Data Collection
    • 19.1.1 Steps for Primary Data Collection
      • 19.1.1.1 Identification of KOL
    • 19.1.2 Backward Integration
    • 19.1.3 Forward Integration
    • 19.1.4 How Primary Research Help Us
    • 19.1.5 Modes of Primary Research
  • 19.2 Secondary Research
    • 19.2.1 How Secondary Research Help Us
    • 19.2.2 Sources of Secondary Research
  • 19.3 Data Validation
    • 19.3.1 Data Triangulation
    • 19.3.2 Top Down & Bottom Up Approach
    • 19.3.3 Cross check KOL Responses with Secondary Data
  • 19.4 Data Representation

Athenaeum AI Dashboard

Research Framework · 70:30 Primary:Secondary

Our Proprietary Methodology

Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global Organ on a chip Systems Market Analysis Market analysis.

01

Primary Intelligence Gathering

Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

02

Secondary Data Triangulation

Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

03

Expert Validation Protocol

Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

04

Athenaeum AI Processing

Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

05

Editorial & QA Review

Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

Data Assurance Metrics
Data Points Validated 10,400+
Expert Interviews 54
Countries Covered 39+
Company Profiles 14+
Forecast Accuracy (Historical) 94.2%
Report Pages 250+
Analytical Coverage
Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

Latest News about Organ on a chip Systems Market

In June 2023, PMI and TissUse GmbH signed a cooperation agreement to use the Multi-Organ-Chip (MOC) platform from TissUse and PMI's InHALES technology.
Source:(https://www.marketsandmarketsblog.com/progressive-projections-organs-on-chips-market-on-a-steady-climb.html)

In June 2023, MatTek Life Sciences announced a strategic partnership with AIM Biotech enabling the availability of AIM Biotech portfolio for sale through MatTek. 
Source:(https://www.mattek.com/mattek-aim-partner-on-organ-on-a-chip-systems/#:~:text=EpiDerm%E2%84%A2-,MatTek%20and%20AIM%20Biotech%20Partner%20on%20Advanced%203D%20Tissue,%2Don%2Da%2DChip%20Systems&text=Boston%2C%20MA%20%E2%80%93%20June%201%2C,available%20for%20sale%20through%20MatTek.)

In June 2023, Dynamic42 raised an undisclosed amount through a Series A funding round to expand internationally. 
Source:(https://silverwoodpartners.com/healthcare-private-placement-and-ma-transactions-review-week-ending-june-19-2023/#:~:text=Dynamic42%3A%20The%20company%20raised%20an,data%20related%20to%20human%20physiology.)

In June 2023, Emulate launched Emulate Chip-A1 to widen its applications in cancer and cosmetic markets. 
Source:(https://www.businesswire.com/news/home/20230626795938/en/Emulate-Unveils-Chip-A1-Expanding-Organ-on-a-Chip-Technology-Applications-Within-the-Cancer-and-Cosmetics-Markets)
 

Sources from Medical Devices & Consumables Industry

How We Serve You

Three Pillars of Market Intelligence

We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global Organ on a chip Systems Market Analysis market.

Service 01

Market Survey

B2B B2C

Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global organ on a chip systems market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

What's Included
  • Buyer intent & sentiment analysis
  • Purchase cycle mapping
  • Price sensitivity research
  • Channel preference profiling
  • Competitive perception study
Most Requested
Service 02

Customized Market Data & Reports

Custom Ready Report

Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

What's Included
  • Ready syndicate report (250+ pages)
  • Custom data scope & segmentation
  • Excel quantitative models
  • Board-ready PPT with key findings
  • Secure cloud portal access
Service 03

Strategic Consultation

With Survey With Report

Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

What's Included
  • Dedicated analyst assigned to you
  • Live walkthrough of findings
  • Strategic Q&A sessions
  • Go-to-market recommendations
  • NDA-protected engagement

Customize This Report

Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.

Get This Report
  • PDF
  • Excel
  • Word
  • Dashboard
  • Cloud
  • AI
Why Trust Us
Memberships & Associations
Certifications & Compliance
Trust Seals & Verification
What Clients Say
Case Studies